GC/52/2 - IARC

elative validity of dietary glycaemic index and glycaemic
load assessed by the food-frequency questionnaire
used in the Dutch cohorts of the European
Prospective Investigation into Cancer and Nutrition.
Br J Nutr 102(4):601-604.
Du H, van der A DL, van Bakel MM, Slimani N, Forouhi
NG, Wareham NJ, Halkjaer J, Tjonneland A,
Jakobsen MU, Overvad K, Schulze MB, Buijsse B,
Boeing H, Palli D, Masala G, Sorensen TI, Saris
WH, Feskens EJ (2009). Dietary glycaemic index,
glycaemic load and subsequent changes of weight
and waist circumference in European men and women.
Int J Obes (Lond) 33(11):1280-1288.
Duarte ML, de Moraes E, Pontes E, Schluckebier
L, de Moraes JL, Hainaut P, Ferreira CG (2009).
Role of p53 in the induction of cyclooxygenase-2 by
cisplatin or paclitaxel in non-small cell lung cancer
cell lines. Cancer Lett 279(1):57-64.
Duell EJ, Bracci PM, Moore JH, Burk RD, Kelsey
KT, Holly EA (2008). Detecting pathway-based
gene-gene and gene-environment interactions in
pancreatic cancer. Cancer Epidemiol Biomarkers
Prev 17(6):1470-1479.
Duell EJ, Maisonneuve P, Baghurst PA, Bueno-de-
Mesquita HB, Ghadirian P, Miller AB, Zatonski W,
Vrieling A, Boffetta P, Boyle P (2009). Menstrual
and reproductive factors and pancreatic cancer in
the SEARCH program of the IARC. Cancer Causes
Control 20(9):1757-1762.
Dwyer T, van der Mei I, Ponsonby AL, Taylor BV,
Stankovich J, McKay JD, Thomson RJ, Polanowski
AM, Dickinson JL (2008). Melanocortin 1 receptor
genotype, past environmental sun exposure, and
risk of multiple sclerosis. Neurology 71(8):583-589.
Edefonti V, Decarli A, La Vecchia C, Bosetti C, Randi
G, Franceschi S, Dal Maso L., Ferraroni M (2008).
Nutrient dietary patterns and the risk of breast and
ovarian cancers. Int J Cancer 122(3):609-613.
Edefonti V, Randi G, Decarli A, La Vecchia C, Bosetti
C, Franceschi S, Dal Maso L, Ferraroni M (2009).
Clustering dietary habits and the risk of breast and
ovarian cancers. Ann Oncol 20(3):581-590.
Egevad L, Carbin BE, Castellanos E, Hellstrom M,
Valdman A (2008). Atypical stromal hyperplasia of
the prostate. Scand J Urol Nephrol 42(5):484-487.
Egevad L (2008). Recent trends in Gleason grading
of prostate cancer: I. Pattern interpretation. Anal
Quant Cytol Histol 30(4):190-198.
Egevad L, Algaba F, Berney DM, Boccon-Gibod
L, Griffiths DF, Lopez-Beltran A, Mikuz G, Varma
M, Montironi R (2008). Handling and reporting of
radical prostatectomy specimens in Europe: a webbased
survey by the European Network of Uropathology
(ENUP). Histopathology 53(3):333-339.
Egevad L (2008). Recent trends in gleason grading
of prostate cancer. II. Prognosis, reproducibility and
reporting. Anal Quant Cytol Histol 30(5):254-260.
Egevad L (2009). Editorial Comment on: Prevalence
of a Tertiary Gleason Grade and Its Impact on
Adverse Histopathologic Parameters in a Contemporary
Radical Prostatectomy Series. Eur Urol
55(2):403.
Egevad L, Algaba F, Berney DM, Boccon-Gibod
L, Griffiths DF, Lopez-Beltran A, Mikuz G, Varma
M, Montironi R (2009). The European Network of
Uropathology: a novel mechanism for communication
between pathologists. Anal Quant Cytol Histol
31(2):90-95.
Egevad L, Hakansson U, Grabe M, Ehrnstrom
R (2009). Urachal signet-cell adenocarcinoma.
Scand J Urol Nephrol 43(1):88-91.
Ekstrom SK, Vajdic CM, Falster M, Engels EA,
Martinez-Maza O, Turner J, Hjalgrim H, Vineis P,
Seniori CA, Bracci PM, Holly EA, Willett E, Spinelli
JJ, La Vecchia C, Zheng T, Becker N, de Sanjose
S., Chiu BC, Dal Maso L., Cocco P, Maynadie M,
Foretova L, Staines A, Brennan P, Davis S, Severson
R, Cerhan JR, Breen EC, Birmann B, Grulich
AE, Cozen W (2008). Autoimmune disorders and
risk of non-Hodgkin lymphoma subtypes: a pooled
analysis within the InterLymph Consortium. Blood
111(8):4029-4038.
El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan
B, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman
C, Galichet L, Cogliano V (2009). A review of
human carcinogens--part D: radiation. Lancet Oncol
10(8):751-752.
Evans AJ, Henry PC, Van der Kwast TH, Tkachuk
DC, Watson K, Lockwood GA, Fleshner NE,
Cheung C, Belanger EC, Amin MB, Boccon-Gibod
L, Bostwick DG, Egevad L, Epstein JI, Grignon DJ,
Jones EC, Montironi R, Moussa M, Sweet JM, Trpkov
K, Wheeler TM, Srigley JR (2008). Interobserver
variability between expert urologic pathologists
for extraprostatic extension and surgical margin status
in radical prostatectomy specimens. Am J Surg
Pathol 32(10):1503-1512.
Farrugia DJ, Agarwal MK, Pankratz VS, Deffenbaugh
AM, Pruss D, Frye C, Wadum L, Johnson
K, Mentlick J, Tavtigian SV, Goldgar DE, Couch
FJ (2008). Functional assays for classification of
BRCA2 variants of uncertain significance. Cancer
Res 68(9):3523-3531.
Feng BJ, Khyatti M, Ben-Ayoub W, Dahmoul S,
Ayad M, Maachi F, Bedadra W, Abdoun M, Mesli S,
Bakkali H, Jalbout M, Hamdi-Cherif M, Boualga K,
Bouaouina N, Chouchane L, Benider A, Ben-Ayed
F, Goldgar DE, Corbex M (2009). Cannabis, tobacco
and domestic fumes intake are associated
with nasopharyngeal carcinoma in North Africa. Br
J Cancer 101(7):1207-1212.
Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle
P, La Vecchia C (2008). Declining mortality from
bladder cancer in Europe. BJU Int 101(1):11-19.
Ferrari P, Day NE, Boshuizen HC, Roddam A, Hoffmann
K, Thiebaut A, Pera G, Overvad K, Lund E,
Trichopoulou A, Tumino R, Gullberg B, Norat T, Slimani
N, Kaaks R, Riboli E (2008). The evaluation of
the diet/disease relation in the EPIC study: considerations
for the calibration and the disease models.
Int J Epidemiol 37(2):368-378.
Ferrari P, Carroll RJ, Gustafson P, Riboli E (2008).
A Bayesian multilevel model for estimating the diet/
disease relationship in a multicenter study with exposures
measured with error: The EPIC study. Stat
Med 27(29):6037-6054.
Ferrari P, Roddam A, Fahey MT, Jenab M, Bamia
C, Ocke M, Amiano P, Hjartaker A, Biessy C, Rinaldi
S, Huybrechts I, Tjonneland A, Dethlefsen C,
Niravong M, Clavel-Chapelon F, Linseisen J, Boeing
H, Oikonomou E, Orfanos P, Palli D, de Magistris
MS, Bueno-de-Mesquita HB, Peeters PHM, Parr
CL, Braaten T, Dorronsoro M, Berenguer T, Gullberg
B, Johansson I, Welch AA, Riboli E, Bingham
S, Slimani N (2009). A bivariate measurement
error model for nitrogen and potassium intakes to
evaluate the performance of regression calibration
in the European Prospective Investigation into Cancer
and Nutrition study. Eur J Clin Nutr 63(Suppl.
4):S179-S187.
Finkbeiner MG, Sawan C, Ouzounova M, Murr R,
Herceg Z (2008). HAT cofactor TRRAP mediates
beta-catenin ubiquitination on the chromatin and the
regulation of the canonical Wnt pathway. Cell Cycle
7(24):3908-3914.
FitzGerald LM, Thomson R, Polanowski A, Patterson
B, McKay JD, Stankovich J, Dickinson JL
(2008). Sequence variants of alpha-methylacyl-
CoA racemase are associated with prostate cancer
risk: a replication study in an ethnically homogeneous
population. Prostate 68(13):1373-1379.
FitzGerald LM, Patterson B, Thomson R, Polanowski
A, Quinn S, Brohede J, Thornton T, Challis
D, Mackey DA, Dwyer T, Foote S, Hannan GN, Stankovich
J, McKay JD, Dickinson JL (2009). Identification
of a prostate cancer susceptibility gene on
chromosome 5p13q12 associated with risk of both
familial and sporadic disease. Eur J Hum Genet
17(3):368-377.
Fortes C, Mastroeni S, Boffetta P, Salvatori V, Melo
N, Bolli S, Pasquini P (2009). Reliability of self-reported
household pesticide use. Eur J Cancer Prev
18(5):404-406.
Franceschi S, Dal Maso L, Rickenbach M, Polesel
J, Hirschel B, Cavassini M, Bordoni A, Elzi L, Ess
S, Jundt G, Mueller N, Clifford GM (2008). Kaposi
sarcoma incidence in the Swiss HIV Cohort Study
before and after highly active antiretroviral therapy.
Br J Cancer 99(5):800-804.
Franceschi S and Clifford GM (2008). Fraction of
cervical neoplasias due to human papillomavirus 16
and 18 in vaccine trials. Int J Cancer 122(3):719-720.
Franceschi S, Plummer M, Clifford G, de Sanjose S,
Bosch X, Herrero R, Munoz N, Vaccarella S (2009).
Differences in the risk of cervical cancer and human
publications du personnel du circ 2008-2009
151